New Zealand Health Minister Denies Connection to Tobacco Industry

Sep.27.2024
New Zealand Health Minister Denies Connection to Tobacco Industry
New Zealand Health Minister Casey Costello strongly denies any ties to tobacco industry at health alliance meeting.

According to a report by MSN on September 27th, New Zealand's Deputy Health Minister Casey Costello strongly denied any connections with the tobacco industry at a health alliance meeting on Tuesday.


According to reports, at the meeting, Costello came under scrutiny from health researchers for loosening anti-smoking laws and providing a document titled "Nicotine is just as harmful as caffeine." The document also criticized the Labour Party's Smoke-Free Generation policy as being "nanny-state nonsense".


The minister recently reduced the consumption tax on heated tobacco products (HTP), making them a more attractive alternative to smoking. These changes align with the demands of tobacco companies, with the main player in the heated tobacco products market being Philip Morris International, which employs two former senior officials of the New Zealand First Party.


I have never had any association with the tobacco industry," Costello said in response to questioning of his credibility at the conference. "Despite extensive efforts, including the Freedom of Information Act and written parliamentary inquiries, no evidence has been found linking me to the tobacco industry, and I have never sought advice from them.


Costello added that according to documents obtained by the New Zealand Broadcasting Corporation under the Official Information Act, there is nothing in conflict with the policy positions of the New Zealand First Party.


Costello stated that the government is committed to achieving the Smoke-Free 2025 goal, which will require approximately 80,000 people to quit smoking by the end of next year to reach this target.


Due to the availability of alternatives such as e-cigarettes, many people have quit smoking. She also mentioned that legislation is being introduced to make smoking alternatives more affordable.


We need a set of appropriate legislation and regulatory systems to provide equal levels of regulation for smoking and other nicotine products.


She emphasized that the Smokefree 2025 goal is just the beginning. "We still need to remain vigilant to ensure that New Zealand remains smokefree, young people do not start smoking or using e-cigarettes, and those who have quit smoking or quit using e-cigarettes do not start again.


Chris Bullen, a tobacco researcher at the University of Auckland, is skeptical about New Zealand's ability to achieve its Smokefree 2025 goal. "I don't believe that the current plan will allow us to reach this goal, and it definitely cannot be achieved without significant costs," he said.


He also stated that repealing the smoke-free legislation is harmful, and believes that introducing new nicotine products into the market without testing is a radical experiment. However, he supports the government's efforts to improve regulation of smoking alternatives.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Product | PMI Introduces VEEV inPrime, Bringing an Induction Vaporization Platform to the Next Generation of the VEEV Portfolio
Philip Morris International (PMI) has introduced VEEV inPrime, the next-generation closed-system vape platform featuring the new AdvanceVape Induction System™. Alongside the new induction platform, PMI has redesigned the pods, e-liquid formulations and user interaction experience. According to PMI and official IQOS websites, VEEV inPrime began a phased European rollout between May and June 2026, with products now available in Greece, Estonia, the United Kingdom and Italy.
Jul.14
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
The Alabama Supreme Court affirmed a lower court’s refusal to issue a preliminary injunction blocking the state’s 2025 electronic nicotine delivery systems law, allowing rules requiring covered products to be U.S.-made or FDA-authorized to remain in effect.
Jul.10
Philip Morris Romania Expands IQOS Boutique Network to 120 Locations With Retail 2.0 Store
Philip Morris Romania Expands IQOS Boutique Network to 120 Locations With Retail 2.0 Store
Philip Morris Romania has opened IQOS Boutique Victoriei in Bucharest, expanding the country’s IQOS retail network to 120 points of sale and advancing a Retail 2.0 concept that combines design, technology, interactive art and urban culture.
PMI
Jul.13
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Russia, Ukraine and Belarus are tightening vape regulation through different tools, from Ukraine’s stronger enforcement push and Belarus’s proposed advertising restrictions to Russia’s new GOST standard and regional sales-ban mechanism. As black-market concerns persist, some Russian experts argue that China’s tightly controlled but legalised model — built around licensing, traceability and taxation — may offer a more effective alternative to blanket prohibition.
Jul.15
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08